J 2013

The importance of admission and discharge BNP assessment in patients hospitalized for acutely decompensated chronic systolic heart failure

LUDKA, Ondřej; Roman ŠTÍPAL; Marta ŠENKYŘÍKOVÁ; Viktor MUSIL; Jan TRNA et. al.

Základní údaje

Originální název

The importance of admission and discharge BNP assessment in patients hospitalized for acutely decompensated chronic systolic heart failure

Autoři

LUDKA, Ondřej (203 Česká republika, domácí); Roman ŠTÍPAL (203 Česká republika, domácí); Marta ŠENKYŘÍKOVÁ (203 Česká republika, domácí); Viktor MUSIL (203 Česká republika, domácí); Jan TRNA (203 Česká republika, domácí); Jiří JARKOVSKÝ (203 Česká republika, garant, domácí); Ladislav DUŠEK (203 Česká republika, domácí) a Jindřich ŠPINAR (203 Česká republika, domácí)

Vydání

Cor et Vasa, Brno, Česká kardiologická společnost, 2013, 0010-8650

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/13:00065641

Organizační jednotka

Lékařská fakulta

UT WoS

000409971600002

Klíčová slova anglicky

Heart failure; Admission and discharge BNP level; Prognosis

Příznaky

Recenzováno
Změněno: 18. 12. 2013 15:28, Soňa Böhmová

Anotace

V originále

Introduction The assessment of B-type natriuretic peptide (BNP) plasma levels is not only useful for the differential diagnosis of acute dyspnea, but also for the prognostic stratification of patients with heart failure. However, available studies that have addressed monitoring of hospitalized patients are burdened with significant limitations: (1) measurement of plasma BNP levels only at admission or at discharge, (2) lack of details regarding the cause of heart failure, and (3) small sample size. Therefore, we conducted a prospective study of all patients presenting to our hospital with acutely decompensated chronic systolic heart failure. Aim To determine the importance of admission and discharge values of BNP and its changes during hospitalization for identification of patients with acutely decompensated chronic systolic heart failure at higher risk of unfavorable course of the disease. Methods A prospective monocentric study determining plasma BNP levels at admission and at discharge in patients hospitalized for acutely decompensated chronic systolic heart failure. Patients: 130 consecutive patients, 77% men, mean age 70 years, body mass index (BMI) 27.8kg/m2; etiology of chronic heart failure-65.9% ischemic heart disease, 29.5% dilated cardiomyopathy, 4.6% others; signs and symptoms at admission-peripheral edema 58.9%, pulmonary rates 88.3%, orthopnea 53.1%, median of admission BNP 1101pg/ml, median of discharge BNP 650pg/ml, median left ventricular ejection fraction 26.5%, average length of hospitalization 9 days. Results During the follow-up (mean 15 months) the total mortality rate reached almost 40% and the annual mortality of our cohort was 29%. The most common causes of death included progression of heart failure and acute coronary syndromes. To evaluate the long-term risk of mortality, we used time-dependent ROC curves for the definition of cut-off values of BNP at admission and discharge. The relationship of BNP levels and the survival of patients was assessed using the hazard ratio (HR) calculated by the Cox proportional hazards model. BNPs at admission and at discharge with a cut-off value of 1699pg/ml and 434.5pg/ml are significant prognostic factors for patients hospitalized for acutely decompensated chronic systolic heart failure with a HR 2.79 and 3.29, respectively. During the follow-up, more than half of the patients required readmission to the hospital. The most common reasons for rehospitalization were cardiovascular causes. Conclusion BNP levels at admission and at discharge are an important predictive factor of survival in patients with acutely decompensated chronic systolic heart failure.

Návaznosti

NS10422, projekt VaV
Název: Interakce mezi pulzním tlakem, rychlostí pulzní vlny, augmentačním indexem, natriuretickými peptidy a echokardiografickými parametry a jejich prediktivní hodnota u akutního srdečního selhání.
Investor: Ministerstvo zdravotnictví ČR, Interakce mezi pulzním tlakem, rychlostí pulzní vlny, augmentačním indexem, natriuretickými peptidy a echokardiografickými parametry a jejich prediktivní hodnota u akutního srdečního selhání